Winton Group’s ProPhase Labs PRPH Stock Holding History

Winton Group’s Portfolio PRPH Stock Details PRPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,633	Closed	-$71.4K	–	837
2023 Q3	$71.4K	Sell	1,633 -43	-3%	-$2.52K	0.01%	740
2023 Q2	$122K	Buy	+1,676	New	+$136K	0.01%	700

Other funds holding PRPH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Winton Group's PRPH Position: Q4 2023 in Review

Winton Group sold out of ProPhase Labs (PRPH) in Q4 2023, closing a stake of 1,633 shares — an estimated $71.4K sold.

Winton Group first reported a position in PRPH in Q2 2023 and held it in 2 quarters. The position peaked at $122K in Q2 2023. 27 funds tracked by Wall St. Rank hold PRPH as of Q4 2023.

Winton Group reported no remaining ProPhase Labs position as of Q4 2023 after selling out during the quarter.
Winton Group sold 1,633 ProPhase Labs shares in Q4 2023, an estimated $71.4K.
Winton Group first reported a position in ProPhase Labs in Q2 2023 and held it in 2 quarters.
Winton Group's ProPhase Labs position peaked at $122K in Q2 2023.
27 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2023.

Based on Winton Group's 13F filing for Q4 2023, filed 12 Feb 2024.